Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-23

Clinical Trial Update: Citalopram Effects on Craving and Dopamine Receptor Availability in Alcoholics [Phase 1]

View source ↗

Summary

Phase 1 trial investigating citalopram's effects on craving and dopamine receptor availability in individuals with alcohol dependence; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram (Citalopram hydrobromide)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Alcohol Dependence | Phase 1 | Status: COMPLETED | Results posted: 2019-07-23